- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04572672
Effect of Pursed-Lip Breathing on Blood Pressure and Heart Rate
September 25, 2020 updated by: Praew Kotruchin, Khon Kaen University
Effect of Pursed-Lip Breathing Combined With Number Counting on Blood Pressure and Heart Rate in Hypertensive Urgency Patients: A Randomized Controlled Trial
Hypertensive urgency (HT urgency) is an alarm sign of uncontrolled hypertension.
It can be aggravated by nonadherent to medication and psychosocial stress.
Mindfulness is beneficial for reducing stress, while deep and slow breathing is effective for blood pressure (BP) lowering.
The objective of the study was to assess the effect of pursed-lip breathing with number counting (PLB with NC) that promotes mindfulness and a deep/slow breathing pattern on BP and heart rate (HR) in the HT urgency patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This was a single-blinded randomized controlled trial.
Patients aged between 18-80 years old, diagnosed with HT urgency, who presented at the emergency room of Srinagarind hospital (a 1000-bed, tertiary-care level university hospital), Khon Kaen University between September 1st, 2019 to June 30th, 2020, were enrolled.
Those with cardiac arrhythmias, acute HF, acute coronary syndromes, acute stroke, acute respiratory failure, alteration of consciousness, and pregnant women were excluded.
This study was approved by the Khon Kaen University Ethical Review Board in Human Research (HE611586).
All patients gave their written informed consent before the enrollment.HT urgency was defined as SBP >180 mmHg and/or DBP >110 mmHg without any signs or symptoms of target organ damages.
Study Type
Interventional
Enrollment (Actual)
112
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Khon Kaen, Thailand, 40002
- Khon Kaen Unversity
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18-80 years old patients who diagnosed with HT urgency, who presented at the emergency room
Exclusion Criteria:
- Patients with cardiac arrhythmias,
- Acute heart failure
- Acute coronary syndromes
- Acute stroke
- Acute respiratory failure
- Alteration of consciousness
- Pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Purse lip breathing with number counting arm
1) Position: The patient lies down in a semi-supine position, the bed is adjusted by 45-60 degrees, 2) Pursed-lip breathing and number counting "one and two" during inspiration, and 3) Number counting, "one, two, three, and four" during exhalation for the first 15 minutes (min) of each hour, total study time was 3 hours or until the patient was discharged from the ER.
|
Pursed-lip breathing and number counting "one and two" during inspiration, and then number counting, "one, two, three, and four" during exhalation.
The nurse advised the patient to continue pursed-lip breathing with number counting for the first 15 minutes (min) of each hour to prevent the patient from being exhausted, total study time was 3 hours, or until the patient was discharged from the ER, or was withdrawn from the study.
|
|
NO_INTERVENTION: Control arm
The patients who were allocated to the control group received usual nursing care i.e. bed rest in a supine position in a quiet area.
Patients were advised to limit their activity.
The frequency of the vital signs monitoring and pharmacologic treatment were the same as the intervention group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of systolic blood pressure
Time Frame: pre-intervention and 3 hours after the intervention
|
The change of systolic blood pressure level was assessed.
|
pre-intervention and 3 hours after the intervention
|
|
Change of diastolic blood pressure
Time Frame: pre-intervention and 3 hours after the intervention
|
The change of diastolic blood pressure level was assessed.
|
pre-intervention and 3 hours after the intervention
|
|
Change of heart rate
Time Frame: pre-intervention and 3 hours after the intervention
|
The change of heart rate was assessed.
|
pre-intervention and 3 hours after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2019
Primary Completion (ACTUAL)
June 30, 2020
Study Completion (ACTUAL)
September 14, 2020
Study Registration Dates
First Submitted
September 17, 2020
First Submitted That Met QC Criteria
September 25, 2020
First Posted (ACTUAL)
October 1, 2020
Study Record Updates
Last Update Posted (ACTUAL)
October 1, 2020
Last Update Submitted That Met QC Criteria
September 25, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HE611586
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertensive Urgency
-
Russian Cardiology Research and Production CenterKRKACompleted
-
Saglik Bilimleri UniversitesiEtimesgut Military HospitalRecruiting
-
Ankara City Hospital BilkentCompletedHypertensive Urgency | Primary HypertensionTurkey (Türkiye)
-
RWTH Aachen UniversityCompletedHypertensive Urgency | Hypertensive EmergencyGermany
-
The Cleveland ClinicEKR Therapeutics, IncCompletedHypertensive UrgencyUnited States
-
Centre Hospitalier Departemental VendeeRecruiting
-
Neuspera Medical, Inc.Active, not recruitingUrinary Urgency IncontinenceUnited States, Netherlands, Belgium
-
Oregon Health and Science UniversityCompleted
-
Albany Medical CollegeNot yet recruiting
-
Neuspera Medical, Inc.RecruitingUrinary Urgency IncontinenceUnited States